US › Healthcare

Sanara Medtech Inc (SMTI)

US · Healthcare · Medical Instruments & Supplies

$34.06+0.18%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$27.8M
Revenue YoY
+18.6%
Net profit
$458,957
Profit YoY
+113.0%
EPS
$0.04
EPS estimate
$0.33
Net margin
1.7%

EPS came in at 0.04 against a street estimate of 0.33 — a miss of 87.7%.

Key statistics

Market cap
$311.3M
P/E
564.3
Forward P/E
212.8
P/B
44.29
Book value
$0.77
EPS (TTM)
$0.06
52-week high
$35.95
52-week low
$16.05
50-day MA
$24.06
200-day MA
$22.42
Beta
1.18

Analyst view

Analysts rate Sanara Medtech Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $35.00.

Shareholding

Insiders
47.95%
Institutions
16.38%

Largest institutional holders

FundStake
BlackRock Inc2.49%
Vanguard Capital Management, LLC1.65%
Royal Bank of Canada1.43%
Stonebridge Wealth Management, LLC1.41%
Geode Capital Management, LLC0.93%
Marshall Wace Asset Management Ltd0.83%
Squarepoint Ops LLC0.80%
Renaissance Technologies Corp0.70%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Sanara Medtech Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.